This gene is significantly downregulated in primary brain tumors. The exact function of the protein encoded by this gene is unknown.[6] Also it has been identified as a possible pathogenic gene involved in the neurogenic inflammation in rosacea.[7]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Wang JR, Li XL, Fan SQ, Tan C, Xiang JJ, Tang K, Wang R, Li GY (Sep 2003). "Expression of LRRC4 has the potential to decrease the growth rate and tumorigenesis of glioblastoma cell line U251". AI Zheng. 22 (9): 897–902. PMID12969517.
Lin JC, Ho WH, Gurney A, Rosenthal A (2004). "The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons". Nat. Neurosci. 6 (12): 1270–6. doi:10.1038/nn1148. PMID14595443. S2CID28353131.
Zhang Q, Wang J, Fan S, et al. (2005). "Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily". FEBS Lett. 579 (17): 3674–82. doi:10.1016/j.febslet.2005.05.058. PMID15967442. S2CID19888187.
Wu M, Gan K, Huang C, et al. (2007). "LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression". J. Neurooncol. 80 (2): 133–42. doi:10.1007/s11060-006-9173-6. PMID16941076. S2CID30590797.
Wu M, Huang C, Li X, et al. (2007). "LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses". J. Cell. Physiol. 214 (1): 65–74. doi:10.1002/jcp.21163. PMID17541939. S2CID44665033.